tiprankstipranks
Trending News
More News >
American Vanguard (AVD)
NYSE:AVD
Advertisement

American Vanguard (AVD) AI Stock Analysis

Compare
293 Followers

Top Page

AVD

American Vanguard

(NYSE:AVD)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 4o)
Rating:55Neutral
Price Target:
$5.50
▲(1.85% Upside)
American Vanguard's overall stock score is primarily impacted by its poor financial performance, which poses significant risks to long-term stability. However, positive technical indicators and recent corporate events provide some optimism, suggesting potential for recovery if financial challenges are addressed.
Positive Factors
Improved EBITDA
The significant improvement in EBITDA indicates better operational efficiency and cost management, which can enhance profitability and financial stability over the long term.
Debt Reduction
Reducing debt levels strengthens the balance sheet, lowers financial risk, and increases the company's flexibility to invest in growth opportunities.
Extended Credit Facility
Extending the credit facility maturity enhances financial stability and provides the company with more time to execute its strategic initiatives without immediate refinancing pressures.
Negative Factors
Revenue Decline
Declining revenue indicates potential challenges in market demand or competitive positioning, which could impact long-term growth and market share.
Negative Profitability Margins
Negative profitability margins suggest operational inefficiencies and financial distress, which can hinder the company's ability to reinvest in growth and innovation.
High Financial Leverage
High financial leverage increases financial risk and can limit the company's ability to respond to market changes or invest in new opportunities, impacting long-term sustainability.

American Vanguard (AVD) vs. SPDR S&P 500 ETF (SPY)

American Vanguard Business Overview & Revenue Model

Company DescriptionAmerican Vanguard Corporation (AVD) is a diversified specialty chemical company that focuses on the development and marketing of innovative crop protection products and other agricultural solutions. Operating primarily in the agricultural sector, the company offers a range of products, including insecticides, herbicides, fungicides, and soil fumigants. AVD is dedicated to enhancing agricultural productivity and sustainability through its advanced chemical formulations and technologies.
How the Company Makes MoneyAmerican Vanguard generates revenue through the sale of its agricultural products, which are sold to distributors and directly to farmers. The company’s primary revenue streams include the sale of crop protection chemicals, specialty fertilizers, and other related products. Additionally, AVD often engages in partnerships and collaborations with other agricultural companies and research institutions to develop new products and technologies, which can enhance its market reach and product offerings. The company's focus on innovation and sustainability also positions it well in a market increasingly driven by environmental considerations, potentially leading to additional revenue opportunities through the development of eco-friendly products.

American Vanguard Earnings Call Summary

Earnings Call Date:Jul 31, 2025
(Q1-2025)
|
% Change Since: |
Next Earnings Date:Nov 11, 2025
Earnings Call Sentiment Negative
The earnings call reflects a mixed performance for American Vanguard in Q1 2025. While the company has made significant improvements in cost management, inventory control, and debt reduction, these efforts were overshadowed by substantial declines in net sales, EBITDA, and gross margins, alongside operational challenges. The reduction in full-year guidance and internal control issues also contribute to a cautious outlook.
Q1-2025 Updates
Positive Updates
Operating Expenses Reduction
Operating expenses dropped by $5 million in Q1 2025 compared to the previous year, indicating effective cost management strategies.
Inventory and Working Capital Improvements
Net trade working capital reduced by $86 million, and channel inventories in the U.S. are at historic lows, indicating efficient inventory management.
Product Sales Increases
Metam sales increased by 14% and Thimet sales by 17% in Q1 2025 compared to the previous year, driven by increased peanut acreage.
Debt Reduction
The company ended Q1 2025 with debt approximately $20 million or 14% lower than the same time last year.
Negative Updates
Decrease in Net Sales and EBITDA
Q1 2025 net sales were $116 million, down from $135 million in the previous year, and adjusted EBITDA was $3 million compared to $15.5 million in the previous year.
Impact of Product Cancellations and Market Weakness
The absence of a canceled product, weakness in the Mexican agave market, and drought conditions in Australia negatively impacted the financial performance.
Lowered Revenue and EBITDA Guidance
Full-year adjusted EBITDA target range decreased to $40 million to $44 million from $45 million to $52 million, with a revised revenue estimate of $535 million to $545 million.
Gross Profit Margin Decline
Gross profit margin declined to 26% during Q1 2025 from 31% in the previous year due to a weaker pricing environment and lower volume.
Internal Control Weaknesses
The company identified internal control weaknesses at its Australian subsidiary and faced delays in SEC filings due to related issues.
Company Guidance
During the American Vanguard First Quarter 2025 Earnings Conference Call, the company provided guidance indicating a challenging start to the year, with first-quarter net sales of $116 million, down from $135 million in the same period last year, and adjusted EBITDA declining to $3 million from $15.5 million. Despite a 14% decrease in revenue year-over-year, driven by continued destocking, the company highlighted operational improvements, including a $5 million reduction in operating expenses and an $86 million improvement in net trade working capital. However, due to a weaker-than-expected first quarter, American Vanguard reduced its full-year adjusted EBITDA target range to $40 million-$44 million from $45 million-$52 million and adjusted revenue estimates to $535 million-$545 million. The company remains optimistic about a recovery, with key products like Metam and Thimet showing growth, and is focused on cost containment and capital management to improve its financial position.

American Vanguard Financial Statement Overview

Summary
American Vanguard faces significant financial challenges, including declining revenues, negative profitability margins, and high financial leverage. Cash flow volatility further exacerbates these issues, suggesting the need for strategic improvements in operational efficiency and financial management.
Income Statement
35
Negative
American Vanguard has experienced significant revenue declines over the past few years. The TTM (Trailing-Twelve-Months) shows a decrease in total revenue from the previous periods. Gross Profit Margin has also decreased significantly, indicating cost management issues. The company is currently operating with negative EBIT and EBITDA margins, reflecting operational inefficiencies and financial distress.
Balance Sheet
45
Neutral
The company's balance sheet shows a high Debt-to-Equity ratio, suggesting a reliance on debt financing, which could pose a risk in terms of financial stability. The Return on Equity (ROE) has turned negative, indicating that the company is not generating sufficient returns from its equity base. The Equity Ratio remains moderate, suggesting some level of balance between debt and equity, but overall financial leverage is high.
Cash Flow
40
Negative
Cash flow analysis indicates challenges, with volatile free cash flow and negative Operating Cash Flow to Net Income ratios in recent years. The Free Cash Flow to Net Income ratio has improved but still indicates inefficiencies in cash generation relative to net income. The growth rate of free cash flow has been unstable, reflecting inconsistent cash flow management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue529.07M547.31M579.37M609.62M556.87M458.70M
Gross Profit110.87M120.32M179.16M241.35M213.24M172.59M
EBITDA-84.96M-81.59M45.08M66.36M53.41M38.87M
Net Income-125.48M-126.34M7.52M27.40M18.59M15.24M
Balance Sheet
Total Assets651.98M636.72M767.55M726.31M694.16M667.18M
Cash, Cash Equivalents and Short-Term Investments14.48M12.51M11.42M20.33M16.29M15.92M
Total Debt208.53M167.81M162.09M76.25M78.08M119.81M
Total Liabilities421.16M403.61M397.54M356.33M321.42M306.45M
Stockholders Equity230.82M233.11M370.01M369.98M372.74M360.74M
Cash Flow
Free Cash Flow18.30M-3.77M-70.81M42.55M77.28M77.95M
Operating Cash Flow20.54M3.92M-58.75M57.10M87.32M89.20M
Investing Cash Flow-1.28M-6.62M-17.02M-14.47M-20.04M-35.80M
Financing Cash Flow-24.27M4.54M66.74M-38.26M-65.87M-43.21M

American Vanguard Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5.40
Price Trends
50DMA
4.74
Positive
100DMA
4.49
Positive
200DMA
4.69
Positive
Market Momentum
MACD
0.21
Positive
RSI
52.76
Neutral
STOCH
63.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVD, the sentiment is Positive. The current price of 5.4 is below the 20-day moving average (MA) of 5.47, above the 50-day MA of 4.74, and above the 200-day MA of 4.69, indicating a neutral trend. The MACD of 0.21 indicates Positive momentum. The RSI at 52.76 is Neutral, neither overbought nor oversold. The STOCH value of 63.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVD.

American Vanguard Risk Analysis

American Vanguard disclosed 33 risk factors in its most recent earnings report. American Vanguard reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

American Vanguard Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
962.05M10.9427.79%9.99%8.15%77.68%
62
Neutral
104.73M-2.030.00%-28.28%-1718.93%
55
Neutral
$153.53M-42.97%0.78%-9.57%-3226.39%
52
Neutral
376.18M-1.81-41.55%11.93%-311.34%
52
Neutral
3.35B75.63-31.07%4.55%-2.05%0.00%
44
Neutral
215.26M-1.160.00%0.00%0.00%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AVD
American Vanguard
5.40
-0.14
-2.53%
UAN
CVR Partners
91.02
29.37
47.64%
IPI
Intrepid Potash
28.25
4.59
19.40%
SMG
Scotts Miracle-Gro Company
58.05
-16.74
-22.38%
BIOX
Bioceres Crop Solutions
1.67
-6.42
-79.36%
LVRO
Lavoro Limited
1.84
-2.16
-54.00%

American Vanguard Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
American Vanguard Extends Loan Agreement with BMO Bank
Positive
Aug 19, 2025

On August 18, 2025, American Vanguard‘s subsidiary, AMVAC Chemical Corporation, amended its senior credit facility with a group of commercial lenders led by BMO Bank. The amendment extends the maturity date of the loan agreement to December 31, 2026, and adjusts the borrowing capacity under the revolving credit facility. This extension is seen as a vote of confidence in American Vanguard’s ongoing transformation and improvement, allowing the management to better demonstrate the company’s earnings potential to investors.

Business Operations and StrategyFinancial Disclosures
American Vanguard Reports Strong Q2 2025 Financial Results
Positive
Aug 1, 2025

On July 31, 2025, American Vanguard reported its financial results for the second quarter ended June 30, 2025. The company achieved a substantial improvement in adjusted EBITDA, which increased by more than 80% compared to the previous year, reaching $11 million. The gross profit margin improved to 31% from 29% last year, driven by enhancements in manufacturing and procurement processes. The company also reduced its debt by $22 million and inventory by $53 million compared to the previous year. CEO Dak Kaye highlighted the company’s progress in business transformation and operational improvements, which have been supported by an early recovery in the agriculture economy. American Vanguard reiterated its full-year 2025 revenue and adjusted EBITDA targets, emphasizing continued efforts to control expenses and maximize investor returns.

Executive/Board ChangesShareholder Meetings
American Vanguard Elects Directors at Annual Meeting
Positive
Jul 7, 2025

At the 2025 Annual Meeting of Stockholders held on July 2, 2025, American Vanguard Corporation announced the election of nine directors, the ratification of Deloitte & Touche LLP as its independent registered public accounting firm for the year ending December 31, 2025, and the approval of its executive compensation policies. All measures received strong support from shareholders, indicating confidence in the company’s leadership and strategic direction.

Delistings and Listing ChangesBusiness Operations and StrategyFinancial DisclosuresRegulatory Filings and Compliance
American Vanguard Regains NYSE Compliance After Filing Delay
Neutral
Jun 9, 2025

On April 2, 2025, American Vanguard Corporation received a notice of noncompliance from the NYSE due to delayed filing of its 2024 Annual Report. By June 6, 2025, the company had resolved the issue, regaining compliance after filing the necessary reports. During its first quarter of 2025, American Vanguard faced challenges such as a 14% revenue decrease compared to the previous year, attributed to continued destocking and strategic adjustments. Despite these hurdles, the company reported improvements in operating expenses and net working capital, and anticipates a stronger second quarter with a solid remainder of 2025.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 01, 2025